BBSRC Portfolio Analyser
Award details
Synthesis and pharmacological characterisation of subtype selective group III metabotropic glutamate receptor agonists
Reference
B14707
Principal Investigator / Supervisor
Professor David Jane
Co-Investigators /
Co-Supervisors
Institution
University of Bristol
Department
Physiology and Pharmacology
Funding type
Research
Value (£)
97,934
Status
Completed
Type
Research Grant
Start date
12/03/2001
End date
12/03/2003
Duration
24 months
Abstract
Agonists for individual subtypes of group III mGlu receptors are currently unavailable. We have recently identified DCPG to be a potent and selective mGlu8 receptor agonist. We aim to further increase the potency and bioavailability of DCPG by synthesising novel analogues. These will be tested on mGlu 4, 6, 7 and 8 receptors in order to determine their selectivity and using this and previous data, pharmacophore models will be constructed for each receptor subtype. Radioligands will also be synthesised allowing binding assays to be set up for native group III mGluRs. In addition, selective agonists will be used by pharmacologists within the group and by our collaborators to assess the physiological roles of mGlu4, 6, 7 and 8 receptors.
Summary
unavailable
Committee
Closed Committee - Biomolecular Sciences (BMS)
Research Topics
X – not assigned to a current Research Topic
Research Priority
X – Research Priority information not available
Research Initiative
X - not in an Initiative
Funding Scheme
X – not Funded via a specific Funding Scheme
I accept the
terms and conditions of use
(opens in new window)
export PDF file
back to list
new search